PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.03M |
| 2 |
Broadcom
AVGO
|
+$3.21M |
| 3 |
Tesla
TSLA
|
+$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
+$1.64M |
| 5 |
Texas Instruments
TXN
|
+$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$27.3M |
| 2 |
Danaher
DHR
|
+$16.8M |
| 3 |
Amgen
AMGN
|
+$12.2M |
| 4 |
Gilead Sciences
GILD
|
+$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Zscaler
ZS
$44.1B
| $699K | 0.04% |
5,983
-780
| -12% | -$91.1K |
|
402
ASE Group
ASX
$24.7B
| $699K | 0.04% |
87,697
+54,526
| +164% | +$435K |
|
403
Albemarle
ALB
$8.69B
| $695K | 0.04% |
3,142
-89
| -3% | -$19.7K |
|
404
Patterson-UTI
PTEN
$2.05B
| $694K | 0.04% |
59,301
+5,073
| +9% | +$59.4K |
|
405
Box
BOX
$4.75B
| $693K | 0.04% |
25,867
+420
| +2% | +$11.3K |
|
406
Intercontinental Exchange
ICE
$98.5B
| $692K | 0.04% |
6,634
-220
| -3% | -$22.9K |
|
407
Amphenol
APH
$146B
| $691K | 0.04% |
16,914
+5,490
| +48% | +$224K |
|
408
Organon & Co
OGN
$2.66B
| $690K | 0.04% |
29,318
+7,565
| +35% | +$178K |
|
409
CareDx
CDNA
$712M
| $686K | 0.04% |
+75,017
| New | +$686K |
|
410
Weatherford International
WFRD
$4.49B
| $681K | 0.04% |
11,472
-1,925
| -14% | -$114K |
|
|
CDMO
411
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $675K | 0.04% |
+35,975
| New | +$675K |
|
|
DCPH
412
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $673K | 0.04% |
+43,547
| New | +$673K |
|
413
General Mills
GIS
$26.5B
| $672K | 0.04% |
7,866
+1,448
| +23% | +$124K |
|
414
Motorola Solutions
MSI
$80.5B
| $670K | 0.04% |
2,340
-403
| -15% | -$115K |
|
415
Vipshop
VIPS
$8.8B
| $669K | 0.04% |
44,081
-35,633
| -45% | -$541K |
|
416
Zentalis Pharmaceuticals
ZNTL
$113M
| $669K | 0.04% |
+38,888
| New | +$669K |
|
417
Vericel Corp
VCEL
$1.6B
| $668K | 0.04% |
+22,767
| New | +$668K |
|
418
Waste Management
WM
$87.7B
| $665K | 0.04% |
4,077
+254
| +7% | +$41.4K |
|
419
Protagonist Therapeutics
PTGX
$3.56B
| $662K | 0.04% |
+28,800
| New | +$662K |
|
420
Noble Corp
NE
$4.79B
| $662K | 0.04% |
16,778
-3,118
| -16% | -$123K |
|
421
Teladoc Health
TDOC
$1.33B
| $656K | 0.04% |
25,345
-633
| -2% | -$16.4K |
|
422
Karyopharm Therapeutics
KPTI
$55.5M
| $652K | 0.04% |
+11,168
| New | +$652K |
|
423
Axsome Therapeutics
AXSM
$6.25B
| $649K | 0.04% |
10,525
+7,416
| +239% | +$457K |
|
|
ICPT
424
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $642K | 0.04% |
+47,828
| New | +$642K |
|
425
Roper Technologies
ROP
$55.2B
| $641K | 0.04% |
1,455
+89
| +7% | +$39.2K |
|